Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis

Mise à jour : Il y a 4 ans
Référence : NCT01008852

Femme et Homme

Extrait

This study is designed to evaluate the safety and efficacy of a dose and dosage regimen of SBI-087 in seropositive patients with active Rheumatoid Arthritis, who are on a stable dose of methotrexate.


Critère d'inclusion

  • active rheumatoid arthritis


Liens